Related Experiment Video
Updated: Jul 3, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Helminths and the IBD hygiene hypothesis.
Joel V Weinstock1, David E Elliott
1Tufts New England Medical Center, Boston, Massachusetts 02111, USA. jweinstock2@tufts-nemc.org
Helminths, or parasitic worms, may protect against inflammatory bowel disease (IBD) by regulating the immune system. Restoring helminth exposure could be a novel therapy for IBD and other immune disorders.
Area of Science:
- Immunology
- Gastroenterology
- Parasitology
Background:
- Helminths are ancient parasites that colonize hosts by modulating immune responses.
- Historically, human helminth colonization was near-universal, but has declined significantly.
- Inflammatory bowel disease (IBD) is linked to immune dysregulation and environmental factors, with lower incidence in less developed countries.
Purpose of the Study:
- To explore the role of helminths in immune regulation.
- To investigate the "IBD hygiene hypothesis" and the impact of helminth absence on immune development.
- To assess the potential of helminth-based therapies for immune-mediated diseases.
Main Methods:
- Review of existing literature on helminth-host interactions and immune responses.
- Analysis of epidemiological data regarding helminth prevalence and IBD incidence.
- Examination of the immunological mechanisms by which helminths modulate host immunity.
Main Results:
- Helminths possess sophisticated mechanisms to suppress host immune responses, preventing pathogen clearance and enabling colonization.
- The absence of helminth exposure is a key environmental factor contributing to the rise of immune disorders like IBD.
- Helminths stimulate immune regulatory pathways and dampen inflammatory responses.
Conclusions:
- The "IBD hygiene hypothesis" suggests that reduced helminth exposure contributes to immune dysregulation and IBD.
- Helminth-derived immunomodulation offers a promising avenue for novel therapeutic strategies against IBD and other autoimmune conditions.
- Early-stage clinical trials for helminth therapies targeting immune diseases are underway.
More Related Videos
Related Concept Videos
Dysbiosis of the Gut Microbiota
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

